QDEL - QuidelOrtho Corporation
NEXT EARNINGS:
May 6, 2026
EPS Est: $0.80
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$30.00
DETAILS
HIGH:
$30.00
LOW:
$30.00
MEDIAN:
$30.00
CONSENSUS:
$30.00
UPSIDE:
36.80%
Market Cap:
1.49B
Volume:
1,131,131
Avg Volume:
1,074,968
52 Week Range:
19.5-42.21
Sector:
Healthcare
Industry:
Medical - Instruments & Supplies
Beta:
0.72
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
6,600
IPO Date:
1991-02-01
EPS (TTM):
-16.69
P/E Ratio:
-1.76
Revenue (TTM):
2.73B
Total Assets:
5.77B
Total Debt:
2.80B
Cash & Equiv:
169.80M
Rev Growth (5Y):
31.3%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
-0.3%
ROCE:
-19.4%
Debt/Equity:
1.46
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-11 | $0.46 | $0.43 | +7.0% | $723.6M | $712.5M | +1.6% |
| 2025-11-05 | $0.80 | $0.51 | +56.9% | $699.9M | $700.2M | 0.0% |
| 2025-08-05 | $0.12 | $0.56 | -78.6% | $615.1M | $676.5M | -9.1% |
| 2025-05-07 | $0.74 | $0.58 | +27.6% | $692.8M | $691.9M | +0.1% |
| 2025-02-12 | $0.63 | $0.55 | +14.5% | $707.8M | $718.2M | -1.4% |
| 2024-11-07 | $0.85 | $0.31 | +174.2% | $727.1M | $698.0M | +4.2% |
| 2024-07-31 | $-0.07 | $-0.21 | +66.7% | $636.3M | $642.1M | -0.9% |
| 2024-05-08 | $0.44 | $0.43 | +2.3% | $709.7M | $695.0M | +2.1% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.73B | 2.78B | 3.00B | 3.27B | 1.70B | 1.66B | 534.89M | 522.28M | 277.74M | 191.60M | 196.13M | 182.62M |
| Net Income | (1.13B) | (2.05B) | (10.10M) | 548.70M | 704.20M | 810.29M | 72.92M | 74.18M | (8.16M) | (13.81M) | (6.08M) | (7.07M) |
| EPS | -16.69 | -30.54 | -0.15 | 9.66 | 16.74 | 19.24 | 1.78 | 1.74 | -0.24 | -0.42 | -0.18 | -0.21 |
| Total Assets | 5.77B | 6.42B | 8.56B | 8.86B | 2.43B | 1.87B | 910.87M | 806.37M | 935.25M | 388.25M | 406.50M | 447.41M |
| Total Debt | 2.80B | 2.68B | 2.61B | 2.85B | 139.30M | 108.50M | 112.30M | 107.57M | 397.45M | 148.42M | 147.91M | 143.08M |
| Cash & Equivalents | 169.80M | 98.30M | 118.90M | 292.90M | 802.80M | 489.94M | 52.77M | 43.70M | 36.09M | 169.51M | 191.47M | 200.90M |
| Operating Cash Flow | 105.20M | 83.00M | 280.20M | 885.30M | 805.87M | 629.76M | 134.49M | 136.34M | 27.71M | 11.81M | 36.31M | 35.69M |
| Free Cash Flow | (83.00M) | (112.10M) | 70.90M | 744.40M | 513.14M | 564.84M | 107.26M | 104.66M | 10.20M | (94,000) | 19.28M | 24.45M |
| FCF per Share | -1.22 | -1.67 | 1.06 | 13.11 | 12.20 | 13.41 | 2.62 | 2.46 | 0.30 | -0.00 | 0.57 | 0.73 |
| Book Value | 1.92B | 2.98B | 5.01B | 4.93B | 1.93B | 1.33B | 559.82M | 425.58M | 227.10M | 200.63M | 218.68M | 245.01M |
| Cash & ST Investments | 202.20M | 98.30M | 167.30M | 345.00M | 828.50M | 489.94M | 52.77M | 43.70M | 36.09M | 169.51M | 191.47M | 200.90M |
| ROC Equity | -0.59 | -0.69 | -0.00 | 0.11 | 0.36 | 0.61 | 0.13 | 0.17 | -0.04 | -0.07 | -0.03 | -0.03 |